Part of the Medicine and Health Sciences Commons

Works by Michael Chrobok in Medicine and Health Sciences

2016

Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach., Evren Alici, Michael Chrobok, Johan Lund, Tahamtan Ahmadi, Imran Khan, Adil D Duru, Hareth Nahi
NSU-MD Faculty Articles

Link